RadNet, Inc.RDNT

NasdaqHealthcareServices-Medical Laboratories
Price (close)
$71.31
Market cap
$5.6B
P/E
—
Revenue (TTM)
$2.3B
Net income
-$21.1M
Dividend yield
—
1-year total return
-5.1%
Net margin
-0.9%
Revenue growth
18.9%
Debt / equity
1.22x

What RadNet, Inc. does.

We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services. As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.

Our Imaging Centers segment provides physicians with capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging ("MRI"), computed tomography ("CT"), positron emission tomography ("PET"), nuclear medicine, mammography, ultrasound, diagnostic radiology ("X-ray"), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. Integral to the imaging center business is our Digital Health operating segment, which sells computerized systems that distribute, display, store and retrieve digital images.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$1.1B$1.3B$1.4B$1.6B$1.8B$2.0B
Net income-$14.8M$24.7M$10.7M$3.0M$2.8M-$18.7M
Free cash flow$139.6M$11.6M$27.0M$44.3M$45.0M$85.6M

More on RDNT.

Figures from RadNet, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.